Table 2.
Variable | Tissue plasminogen activator group (n = 20) | Placebo group (n = 20) | P value |
---|---|---|---|
Age (years) | 8.5 ± 3.9 | 10.5 ± 3.4 | 0.10 |
Body weight (kg) | 5.1 ± 1.1 | 5.1 ± 1.1 | 0.87 |
Rectal temperature (ºF) | 96.4 ± 2.5 | 96.2 ± 2.6 | 0.81 |
Affected limb lactate (mmol/l) | 10.9 ± 3.3 | 11.6 ± 3.7 | 0.62 |
Heart rate (beats/min) | 193 ± 27 | 195 ± 37 | 0.95 |
Respiratory rate (breaths/min) | 60 (32–120) | 60 (30–140) | 0.39 |
Clinicopathologic variables | |||
Sodium (mEq/l) | 152.9 ± 5.1 | 152.4 ± 5.1 | 0.76 |
Potassium (mEq/l) | 3.9 ± 0.6 | 4.0 ± 0.8 | 0.70 |
Creatinine (mg/dl) | 1.4 (0.9–2.3) | 1.6 (1.0–3.2) | 0.06 |
Lactate (mmol/l) | 3.6 ± 1.2 | 3.1 ± 0.9 | 0.24 |
Packed cell volume (%) | 42 ± 9 | 42 ± 8 | 0.89 |
Total protein (g/dl) | 7.7 (6.4–10.6) | 8.0 (6.4–10.0) | 0.77 |
FATE characteristics | |||
Limb score | 10 (6–11) | 10 (6–10) | 0.31 |
Cardiogenic FATE (%) | 95 | 90 | 1.00 |
Congestive heart failure (%) | 85 | 60 | 0.15 |
FATE to admission time (h) | 2.4 (0.3–5.5) | 2.0 (0.25–5.5) | 0.57 |
Admission to needle time (h) | 1.2 (0.3–3.7) | 1.3 (0.5–4.5) | 0.91 |
FATE to needle time (h) | 4.0 ± 1.7 | 3.8 ± 1.2 | 0.63 |